Skip to Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

17 April 2025

36 Pages

Therapeutic Potential of Tricyclic Pyridazinone-Based Molecules: An Overview

,
,
,
,
,
and
Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni 23/A, 07100 Sassari, Italy
*
Authors to whom correspondence should be addressed.

Abstract

Pyridazin-3(2H)one-based molecules have always attracted the attention of medicinal chemists due to their different pharmacological properties. The incorporation of such nuclei in therapeutically active molecules either as monocyclic units or as fused bi- or tricyclic scaffolds results in a wide range of pharmacological effects such as anti-inflammatory, analgesic, anticancer, antimicrobial, antiviral, cardiovascular-protective, antiulcer, and many other useful pharmacological activities. In accordance with our consolidated experience gained over the years in the chemistry and biology of tricyclic pyridazin-3(2H)ones, this review summarizes SAR studies of such pyridazinone-based polycyclic compounds endowed with various biological and therapeutic properties.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.